Vaccine sorted – Emerging markets and not tech may be the smart play

Stephen shares his views on the exuberant reaction of markets around the world to Pfizer’s announcement of a vaccine with 90% effectiveness.

He also gives his views on the risks to watch out for in markets and highlights potential opportunities that are not the usual suspects, like the SGX.

Guest: Stephen Innes, Chief Global Market Strategist at AxiCorp

Presenter: Brian Fernandez